Site logo
Site logo
Mobile logo
  • Home
  • About
  • NYC TMS Services
  • NYC Spravato Services
  • Insurance Coverage
  • FAQs
  • Blog
  • Contact

Spravato

Depression Shot of a young couple spending time together at the beach, demonstrating how ketamine can improve quality of life for people with Depression
July 15, 2025in Depression 0 Comments 0 Likes

Does Ketamine Improve Quality of Life for People with Depression?

When you hear the word “ketamine,” you might think of club drugs or even anesthesia. But in recent years, ketamine—and its close cousin, esketamine (Spravato)—has been receiving much attention in

by Dr. Bryan Bruno, Medical Director
Depression A pharmacist explaining the Auvelity experience that patients have with this new medication.
March 12, 2024in Depression 0 Comments 0 Likes

A New Antidepressant: Discussing Patients’ Auvelity Experience

Whenever a new antidepressant becomes available, patients will want to know what it is like to take it. For this reason, we bring you this discussion of the Auvelity experience

by Dr. Bryan Bruno, Medical Director

Recent Posts

  • Combatting a Low Rate of Long-Term Antidepressant Success with TMS Therapy
  • Your Spravato Medication Guide: An In-Depth Review for New York City Patients
  • New Hope for NYC: Esketamine for Anxiety and Comorbid Treatment-Resistant Depression
  • Spravato NYC: A Breakthrough Nasal Spray for Treatment-Resistant Depression
  • Understanding the Paradoxical Effect of Antidepressants

Categories

  • anxiety
  • COVID-19
  • Depression
  • Depression Factors
  • Loneliness
  • Manhattan TMS
  • Resources
  • Support
  • TMS
  • TMS Maintenance
  • Treatment
  • Types of Depression
  • Uncategorized
Site Map
  • Home
  • About
  • Services
  • Insurance Coverage
  • Frequently Asked Questions
  • Blog
Copyright © 2024 Mid City TMS. All rights reserved. Designed by Online Optimism.
280 Madison Ave, Suite 1102, New York, NY 10016
div#stuning-header .dfd-stuning-header-bg-container {background-size: initial;background-position: top center;background-attachment: initial;background-repeat: initial;}#stuning-header div.page-title-inner {min-height: 650px;}#main-content .dfd-content-wrap {margin: -10px;} #main-content .dfd-content-wrap > article {padding: 10px;}@media only screen and (min-width: 1101px) {#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars {padding: 0 20px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child {border-top: 20px solid transparent; border-bottom: 10px solid transparent;}#layout.dfd-portfolio-loop > .row.full-width #right-sidebar,#layout.dfd-gallery-loop > .row.full-width #right-sidebar {padding-top: 10px;padding-bottom: 10px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars .sort-panel,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars .sort-panel {margin-left: -20px;margin-right: -20px;}}#layout .dfd-content-wrap.layout-side-image,#layout > .row.full-width .dfd-content-wrap.layout-side-image {margin-left: 0;margin-right: 0;}